Discordant <i>In Vitro</i> and <i>In Vivo</i> Chemopotentiating Effects of the PARP Inhibitor Veliparib in Temozolomide-Sensitive versus -Resistant Glioblastoma Multiforme Xenografts

• 資料種別: 記事
• タイトル: Discordant <i>In Vitro</i> and <i>In Vivo</i> Chemopotentiating Effects of the PARP Inhibitor Veliparib in Temozolomide-Sensitive versus -Resistant Glioblastoma Multiforme Xenografts
• 著者標目: Shiv K. Gupta; Ann C. Mladek; Brett L. Carlson; Felix Boakye-Agyeman; Katrina K. Bakken; Sani H. Kizilbash; Mark A. Schroeder; Joel Reid; Jann N. Sarkaria
• 出版年月日等: 2014-07-14
• 出版年（W3CDTF）: 2014-07-14
• タイトル（掲載誌）: Clinical Cancer Research
• 巻号年月日等（掲載誌）: 20 14
• 掲載巻: 20
• 掲載号: 14
• 掲載ページ: 3730-3741
• 掲載年月日（W3CDTF）: 2014-07-14
• ISSN（掲載誌）: 10780432
• 出版事項（掲載誌）: American Association for Cancer Research (AACR)
• 対象利用者: 一般
• DOI: 10.1158/1078-0432.ccr-13-3446
• 作成日（W3CDTF）: 2014-05-17
• 関連情報（URI）: https://aacrjournals.org/clincancerres/article-pdf/20/14/3730/2019471/3730.pdf
• 参照: Current trends in mouse models of glioblastoma; https://cir.nii.ac.jp/crid/1360002215417947776; Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells; https://cir.nii.ac.jp/crid/1360013168810998400
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Crossref; https://www.crossref.org

• 要約等: <jats:title>Abstract</jats:title> <jats:p>Purpose: Effective sensitizing strategies potentially can extend the benefit of temozolomide ...